Nonconvulsive status epilepticus (NCSE) encompasses a wide range of diagnoses with variable outcomes and treatment recommendations. In children, NCSE can be observed in various conditions, including ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Hospitalization ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Prehospital ...

Hypothermia did not improve the rate of good functional outcomes at 90 days over standard antiepileptic therapy in patients with convulsive status epilepticus receiving mechanical ventilation, a new ...

Please provide your email address to receive an email when new articles are posted on . A Bay Area neurotechnology firm has announced the commercial release of a novel artificial intelligence-based ...

This page lists all known medications that could potentially lead to 'Status epilepticus' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Delayed treatment of status epilepticus is known to increase seizure duration, but new research shows that a delay of more than 10 minutes from seizure onset increases morbidity and risk of death. The ...

Status epilepticus is a condition that is characterized by repeated seizures and is a medical emergency. Treatment is usually with a Benzodiazepine such as Diazepam or Lorazepam etc. There have been ...

Please provide your email address to receive an email when new articles are posted on . Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status ...

A rare condition that presents with refractory and many times super-refractory status epilepticus, NORSE, including its subtype febrile infection related epilepsy syndrome (FIRES), is heterogeneous ...

Status epilepticus (SE) is the most common neurologic emergency, with rates estimated between 1.3 and 81 cases per 100,000 people per year. Mortality estimates also range widely, between 3% and 50% in ...

Cefepime is a fourth-generation cephalosporin with a spectrum of antibacterial activity including both Gram-positive and Gram-negative organisms. Consequently, it is a useful extended-spectrum agent ...